These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 21056914
1. Serology of celiac disease in gluten-sensitive ataxia or neuropathy: role of deamidated gliadin antibody. Rashtak S, Rashtak S, Snyder MR, Pittock SJ, Wu TT, Gandhi MJ, Murray JA. J Neuroimmunol; 2011 Jan; 230(1-2):130-4. PubMed ID: 21056914 [Abstract] [Full Text] [Related]
2. Diagnostic efficacy of the ELISA test for the detection of deamidated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease. Tonutti E, Visentini D, Picierno A, Bizzaro N, Villalta D, Tozzoli R, Kodermaz G, Carroccio A, Iacono G, Teresi S, La Chiusa SM, Brusca I. J Clin Lab Anal; 2009 Jan; 23(3):165-71. PubMed ID: 19455636 [Abstract] [Full Text] [Related]
3. Application of Deamidated Gliadin Antibodies in the Follow-Up of Treated Celiac Disease. de Chaisemartin L, Meatchi T, Malamut G, Fernani-Oukil F, Hosking F, Rault D, Bellery F, Cellier C, Dragon-Durey MA. PLoS One; 2015 Jan; 10(8):e0136745. PubMed ID: 26322980 [Abstract] [Full Text] [Related]
7. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Rashtak S, Ettore MW, Homburger HA, Murray JA. Clin Gastroenterol Hepatol; 2008 Apr; 6(4):426-32; quiz 370. PubMed ID: 18304884 [Abstract] [Full Text] [Related]
8. Lack of serologic evidence to link IgA nephropathy with celiac disease or immune reactivity to gluten. Moeller S, Canetta PA, Taylor AK, Arguelles-Grande C, Snyder H, Green PH, Kiryluk K, Alaedini A. PLoS One; 2014 Apr; 9(4):e94677. PubMed ID: 24732864 [Abstract] [Full Text] [Related]
9. Extension of the celiac intestinal antibody (CIA) pattern through eight antibody assessments in fecal supernatants from patients with celiac disease. Di Tola M, Marino M, Casale R, Di Battista V, Borghini R, Picarelli A. Immunobiology; 2016 Jan; 221(1):63-9. PubMed ID: 26271834 [Abstract] [Full Text] [Related]
10. The neurologic significance of celiac disease biomarkers. McKeon A, Lennon VA, Pittock SJ, Kryzer TJ, Murray J. Neurology; 2014 Nov 11; 83(20):1789-96. PubMed ID: 25261501 [Abstract] [Full Text] [Related]
11. Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease. Ankelo M, Kleimola V, Simell S, Simell O, Knip M, Jokisalo E, Tarkia M, Westerlund A, He Q, Viander M, Ilonen J, Hinkkanen AE. Clin Exp Immunol; 2007 Nov 11; 150(2):285-93. PubMed ID: 17803713 [Abstract] [Full Text] [Related]
12. Dynamics of celiac disease-specific serology after initiation of a gluten-free diet and use in the assessment of compliance with treatment. Sugai E, Nachman F, Váquez H, González A, Andrenacci P, Czech A, Niveloni S, Mazure R, Smecuol E, Cabanne A, Mauriño E, Bai JC. Dig Liver Dis; 2010 May 11; 42(5):352-8. PubMed ID: 19679520 [Abstract] [Full Text] [Related]
17. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D. Ann Neurol; 2008 Sep 11; 64(3):332-43. PubMed ID: 18825674 [Abstract] [Full Text] [Related]
18. Identification of tissue transglutaminase as the autoantigen of celiac disease. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. Nat Med; 1997 Jul 11; 3(7):797-801. PubMed ID: 9212111 [Abstract] [Full Text] [Related]